Furthermore, MEK signalling has also been shown to regulate PD-L1 expression in tumour cells specifically via epidermal growth factor- and interferon-gamma-induced PD-L1 expression in lung adenocarcinoma cells and blockade of MEK1/2 attenuated PD-L1 upregulation29. The gene discussed is MAP2K1; the disease is lung adenocarcinoma.